- Support QC lab functions by providing solutions to a variety of technical problems.
- Participate in software/computer system validation, IT for software/computer applications, and fulfill all networking and security requirements for enterprise software applications.
- Facilitate and coordinate training of new and existing local admins, preparing training materials as necessary.
- Execute protocols, reports, investigations, change management, document authoring, etc., using Veeva on behalf of the department.
- Support QC information system lifecycle management activities from concept, development, validation, implementation, maintenance, to retirement.
- Provide audit support to the labs with a strong understanding of administration and data integrity of validated GMP systems.
- Self-manage tasks and assignments effectively, as well as lead small projects within the team, collaborating with peers, global counterparts, and leadership.
Essential Skills/Experience
- Bachelor’s Degree in a science-related field.
- 5+ years in systems or lab setting.
Desirable Skills/Experience
- Degree in Information Systems/Technology or Biotechnology related field.
- Experience in information management and/or a scientific lab setting.
At AstraZeneca, our work in Quality is both important and valued. We are at the forefront of innovation, constantly trialling the latest models and technologies to improve reliability and excellence in our processes. Our team is proactive, science-based, and solutions-oriented, always striving to deliver what will have the biggest impact on our patients. We foster an inclusive and friendly community where each voice matters, empowering us to work effectively in a high-risk environment. With a clear focus on growth and innovation, there are always exciting opportunities to quality assure new products as we go to market around the world.
Join us at AstraZeneca and make a real difference in patients' lives!
The annual base pay (or hourly rate of compensation) for this position ranges from $100,786.00 to $151,180.00 Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors
Date Posted
01-Apr-2025Closing Date
Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.","datePosted":"2025-04-02T07:09","employmentType":"FULL_TIME","jobLocation":[{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Frederick, MD, USA","addressRegion":null,"addressCountry":"United States"}}],"directApply":false,"hiringOrganization":{"@type":"Organization","name":"AstraZeneca","sameAs":"https://www.astrazeneca.com/","logo":"https://storage.googleapis.com/simplify-imgs/companies/29be16e3-39fd-4c52-a740-3a692701c884/logo.png"},"baseSalary":{"@type":"MonetaryAmount","currency":"USD","value":{"@type":"QuantitativeValue","minValue":100786,"maxValue":151180,"unitText":"YEAR"}},"identifier":{"@type":"PropertyValue","name":"AstraZeneca","value":"29be16e3-39fd-4c52-a740-3a692701c884"}}Full-Time
Confirmed live in the last 24 hours
Develops and commercializes prescription medicines
$100.8k - $151.2k/yr
Senior
Frederick, MD, USA
Upload your resume to see how it matches 3 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatments; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before they reach the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and collaborating with other organizations to improve their research capabilities.
Company Size
10,001+
Company Stage
IPO
Headquarters
Cambridge, United Kingdom
Founded
1913
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Flexible Work Hours
AstraZeneca unit faces class-action suit over alleged soliris monopoly.
In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.
11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast
AstraZeneca unveils breakthrough data on vaccines and antibody therapies for infections.